Analysis features an integral part of the Exclusive Capital research team. In addition to the spontaneous fundamental insights our experts provide, in-depth analysis is one major element that our experts apply.
28 Jul 2021
The biotech companies behind the successful development of Covid vaccines have seen their stocks skyrocketing by almost 300% since the start of the year, after rising...
21 Jul 2021
Global financial markets have started the week with significant losses as growing concerns over the impact of the “Delta” variant on global economic recovery, have hit risk-sensitive stocks and...
29 Jun 2021
Massive pandemic-relief fiscal spending, the progress with vaccination programs, and the low-interest rate environment have been boosting financial assets around the world, despite the recent spike...